ConductScience.org, home

Trial · NCT07813156

Registered outcomes53

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryProportion of patients completing the 7 sessions of the programat the end of the program at 12 weeks
SecondaryProportion of ineligible participants after screening and inclusionat inclusion visit
SecondaryNumber of participants who withdrew until the end of the program (Dropout rates).at the end of the program at 12 weeks
SecondaryPerceived level of interest with a satisfaction questionnaire (The Satisfaction with Therapy and Therapist Scale-Revised (STTS-R)At the end the program at 12 weeks
SecondaryParticipants' experience of the program (practical organization of the sessions, understanding and expectations, overall acceptability and recommendations) using qualitative questionnaireet the end of the program at 12 weeks
SecondaryPerceived benefits of the program as reported by the participant at 3 months post treatment using qualitative questionnaireat 24 weeks
SecondaryPerceived benefits of the program as reported by the participant at 9 months post treatment using qualitative questionnaireat 48 weeks
SecondaryPerceived benefits of the program as reported by one of the patient's relatives at 3 months post treatment using qualitative questionnaireat 24 weeks
SecondaryPerceived benefits of the program as reported by one of the patient's relatives at 9 months post treatment using qualitative questionnaireat 48 weeks
SecondaryLevel of achievement of individualized functional goals, assessed using GAS (treated as continuous data transformed by the zscore approach)at 24 weeks
SecondaryLevel of achievement of individualized functional goals, assessed using GAS (treated as continuous data transformed by the zscore approach)at 48 weeks
SecondaryFunctional autonomy with the Penn's Parkinson Autonomy Questionnaire-15 items (PDAQ-15)at inclusion visit
SecondaryFunctional autonomy with the Penn's Parkinson Autonomy Questionnaire-15 items (PDAQ-15)at 24 weeks
SecondaryFunctional autonomy with the Penn's Parkinson Autonomy Questionnaire-15 items (PDAQ-15)at 48 weeks
SecondaryGlobal subjective cognitive complaints : Subjective Cognitive Complaints Questionnaire for Parkinson's disease (SCCQ-PD)at inclusion visit
SecondaryGlobal subjective cognitive complaints : Subjective Cognitive Complaints Questionnaire for Parkinson's disease (SCCQ-PD)at 24 weeks
SecondaryGlobal subjective cognitive complaints : Subjective Cognitive Complaints Questionnaire for Parkinson's disease (SCCQ-PD)at 48 weeks
SecondaryQuality of life using the Parkinson's Disease Questionnaire (PDQ-39)at inclusion visit
SecondaryQuality of life using the Parkinson's Disease Questionnaire (PDQ-39)at 24 weeks
SecondaryQuality of life using the Parkinson's Disease Questionnaire (PDQ-39)at 48 weeks

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07813156/registered